TSS, a global company specializing in temperature monitoring for the pharmaceutical supply chain, is proud to announce that it has received an 'SME B' rating from the 2024 CDP SME Climate Score. This recognition highlights TSS’s commitment to being open about its environmental impact and taking steps to reduce it.

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.

February 11 marks the International Day of Women and Girls in Science, a day dedicated to recognizing the invaluable contributions of women in STEM fields and inspiring future generations to follow in their footsteps.

Curious about how to up-scale you Clinical Trials? Join us at the 26th Annual Clinical Trial Supply Europe in Barcelona to explore your possibilities for optimizing the supply chain.

As the global healthcare industry focuses more on sustainability, temperature management in clinical trials is becoming more important. Research organizations and clinical trial sponsors are starting to see that making clinical trial processes more sustainable is not only good for the environment but also improves efficiency and cuts costs.

Customer onboarding is one of the most important steps in making sure your customers are happy and confident in using your product. At TSS, we help companies in life sciences monitor complex temperature budgets with our advanced automated cloud software and temperature loggers. Making the onboarding process smooth is key to long-term customer satisfaction.

Is it possible to cut costs, increase efficiency, and improve quality—all at the same time? The GSK (GlaxoSmithKline) UAE division and their main logistics company GAC (Gulf Agency Company) exceeded their expectations when they implemented temperature monitoring solutions from TSS in outbound shipments from Dubai. Additionally, they reassured the safety of what's most valuable—the patient.

Seamless monitoring of direct-to-patient shipments within an end-to-end calculation engine enables a digital release in patient's homes. Site centric technology also allows for a decentralized and proactive approach, reducing waste. Furthermore, digitalizing temperature management end-to-end enables a faster release of products for all types of trials and creates a foundation for successful decentralized drives.

Pharmaceutical supply chains are often defined by a lack of connectivity between tiers, stakeholders and operational islands. It doesn’t have to be that way.

Digital transformation is having a huge impact on pharma supply chains, supporting patient safety and giving companies a competitive advantage. But key to this process are the integrations between different systems.

Without a doubt, uncertainty and unpredictability will continue to increase. Whether you‘re a pharmaceutical company dealing with temperature excursions, or a manufacturer relying on critical assembly-line components, you’re bound to be affected. The amount of disruption in today’s business climate demands the ability to respond quickly, which can only be done if the entire supply chain is visible.

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.

Curious about how to up-scale you Clinical Trials? Join us at the 26th Annual Clinical Trial Supply Europe in Barcelona to explore your possibilities for optimizing the supply chain.

As the global healthcare industry focuses more on sustainability, temperature management in clinical trials is becoming more important. Research organizations and clinical trial sponsors are starting to see that making clinical trial processes more sustainable is not only good for the environment but also improves efficiency and cuts costs.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the pharmaceutical industry, maintaining precise temperature control is paramount to ensuring product quality and compliance with regulatory standards. The integrity of pharmaceutical products is heavily reliant on storage conditions, with deviations in temperature potentially compromising their efficacy and safety.

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.

Supply chain digitalization, or rather digital transformation, provides a path to sustainable solutions for many of the challenges in managing the pharmaceutical industry’s supply chain such as compliance, traceability, end-to-end visibility, error-reduction, quality assurance and process efficiencies.

Digital temperature monitoring along every step of the pharmaceutical supply chain is quickly becoming the new norm. Government guidelines like the EU’s Good Distribution Practices (GDP) and the guidelines of UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have seen to increased uptake of digital temperature monitoring across the Europe’s pharmaceutical industry.

Learn how one of the world’s largest pharma organisations saves millions of dollars and thousands of tonnes of CO2 with a clean, simple, and efficient supply chain.

When TSS received the request to support Sandoz, the Novartis generics and biosimilar division, from its client Novartis, a multinational pharmaceutical company based in Switzerland, citing their need for urgent support with surveillance of critical shipments related to a COVID-19, the obvious solution was TSS Real-Time Monitoring solution.

For companies in the pharmaceutical and life sciences industry, GxP data is a critical element of supply chain best practices. Indeed, there is hardly any requirement, from visibility to synchronized logistics, which does not rely on accessing the right data.

Curious about how to up-scale you Clinical Trials? Join us at the 26th Annual Clinical Trial Supply Europe in Barcelona to explore your possibilities for optimizing the supply chain.

The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In light of the recent EMA and FDA guidelines, this session will discuss what role temperature monitoring may play in decentralized (DCT) and direct-to-patient (DTP) studies.

Where do the majority of your temperature excursions occur? Why not eliminate them?

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.